vs

Side-by-side financial comparison of Hasbro (HAS) and Steris (STE). Click either name above to swap in a different company.

Steris is the larger business by last-quarter revenue ($1.5B vs $1.4B, roughly 1.0× Hasbro). Hasbro runs the higher net margin — 13.9% vs 12.9%, a 1.1% gap on every dollar of revenue. On growth, Hasbro posted the faster year-over-year revenue change (31.3% vs 9.2%). Hasbro produced more free cash flow last quarter ($389.5M vs $199.5M). Over the past eight quarters, Hasbro's revenue compounded faster (38.2% CAGR vs 15.8%).

Hasbro, Inc. is an American multinational toy manufacturing and entertainment holding company founded on December 6, 1923 by Henry, Hillel and Herman Hassenfeld and is incorporated and headquartered in Pawtucket, Rhode Island. Hasbro owns the trademarks and products of Kenner, Milton Bradley, Parker Brothers, and Wizards of the Coast, among others. As of August 2020, over 81.5% of its shares were held by large financial institutions.

Steris plc is an American-Irish-based medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, and has been legally registered in Dublin, Ireland, for tax purposes since 2018. Previously the company was registered in the United Kingdom from 2014 to 2018.

HAS vs STE — Head-to-Head

Bigger by revenue
STE
STE
1.0× larger
STE
$1.5B
$1.4B
HAS
Growing faster (revenue YoY)
HAS
HAS
+22.1% gap
HAS
31.3%
9.2%
STE
Higher net margin
HAS
HAS
1.1% more per $
HAS
13.9%
12.9%
STE
More free cash flow
HAS
HAS
$190.0M more FCF
HAS
$389.5M
$199.5M
STE
Faster 2-yr revenue CAGR
HAS
HAS
Annualised
HAS
38.2%
15.8%
STE

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
HAS
HAS
STE
STE
Revenue
$1.4B
$1.5B
Net Profit
$201.6M
$192.9M
Gross Margin
68.7%
43.8%
Operating Margin
20.6%
18.3%
Net Margin
13.9%
12.9%
Revenue YoY
31.3%
9.2%
Net Profit YoY
687.8%
11.2%
EPS (diluted)
$1.46
$1.96

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HAS
HAS
STE
STE
Q4 25
$1.4B
$1.5B
Q3 25
$1.4B
$1.5B
Q2 25
$980.8M
$1.4B
Q1 25
$887.1M
$1.5B
Q4 24
$1.1B
$1.4B
Q3 24
$1.3B
$1.3B
Q2 24
$995.3M
$1.3B
Q1 24
$757.3M
$1.1B
Net Profit
HAS
HAS
STE
STE
Q4 25
$201.6M
$192.9M
Q3 25
$233.2M
$191.9M
Q2 25
$-855.8M
$177.4M
Q1 25
$98.6M
$145.7M
Q4 24
$-34.3M
$173.5M
Q3 24
$223.2M
$150.0M
Q2 24
$138.5M
$145.4M
Q1 24
$58.2M
$-1.4M
Gross Margin
HAS
HAS
STE
STE
Q4 25
68.7%
43.8%
Q3 25
70.1%
44.2%
Q2 25
77.0%
45.1%
Q1 25
76.9%
43.3%
Q4 24
67.4%
44.5%
Q3 24
70.4%
43.6%
Q2 24
76.1%
44.7%
Q1 24
73.0%
40.2%
Operating Margin
HAS
HAS
STE
STE
Q4 25
20.6%
18.3%
Q3 25
24.6%
18.2%
Q2 25
-81.4%
17.7%
Q1 25
19.2%
14.6%
Q4 24
5.4%
17.9%
Q3 24
23.6%
16.5%
Q2 24
21.3%
14.5%
Q1 24
15.3%
22.0%
Net Margin
HAS
HAS
STE
STE
Q4 25
13.9%
12.9%
Q3 25
16.8%
13.1%
Q2 25
-87.3%
12.8%
Q1 25
11.1%
9.8%
Q4 24
-3.1%
12.7%
Q3 24
17.4%
11.3%
Q2 24
13.9%
11.4%
Q1 24
7.7%
-0.1%
EPS (diluted)
HAS
HAS
STE
STE
Q4 25
$1.46
$1.96
Q3 25
$1.64
$1.94
Q2 25
$-6.10
$1.79
Q1 25
$0.70
$1.48
Q4 24
$-0.25
$1.75
Q3 24
$1.59
$1.51
Q2 24
$0.99
$1.46
Q1 24
$0.42
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HAS
HAS
STE
STE
Cash + ST InvestmentsLiquidity on hand
$423.7M
Total DebtLower is stronger
$1.9B
Stockholders' EquityBook value
$565.5M
$7.2B
Total Assets
$5.6B
$10.6B
Debt / EquityLower = less leverage
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HAS
HAS
STE
STE
Q4 25
$423.7M
Q3 25
$319.2M
Q2 25
$279.7M
Q1 25
$171.7M
Q4 24
$155.2M
Q3 24
$172.2M
Q2 24
$198.3M
Q1 24
$207.0M
Total Debt
HAS
HAS
STE
STE
Q4 25
$1.9B
Q3 25
$1.9B
Q2 25
$1.9B
Q1 25
$1.9B
Q4 24
$2.0B
Q3 24
$2.2B
Q2 24
$2.2B
Q1 24
$3.1B
Stockholders' Equity
HAS
HAS
STE
STE
Q4 25
$565.5M
$7.2B
Q3 25
$433.8M
$7.0B
Q2 25
$269.7M
$7.0B
Q1 25
$1.2B
$6.6B
Q4 24
$1.2B
$6.4B
Q3 24
$1.3B
$6.6B
Q2 24
$1.2B
$6.4B
Q1 24
$1.0B
$6.3B
Total Assets
HAS
HAS
STE
STE
Q4 25
$5.6B
$10.6B
Q3 25
$5.5B
$10.4B
Q2 25
$5.2B
$10.4B
Q1 25
$6.0B
$10.1B
Q4 24
$6.3B
$10.0B
Q3 24
$7.2B
$10.2B
Q2 24
$6.9B
$10.1B
Q1 24
$6.2B
$11.1B
Debt / Equity
HAS
HAS
STE
STE
Q4 25
0.27×
Q3 25
0.27×
Q2 25
0.27×
Q1 25
0.29×
Q4 24
0.32×
Q3 24
0.33×
Q2 24
0.35×
Q1 24
0.50×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HAS
HAS
STE
STE
Operating Cash FlowLast quarter
$403.2M
$298.2M
Free Cash FlowOCF − Capex
$389.5M
$199.5M
FCF MarginFCF / Revenue
26.9%
13.3%
Capex IntensityCapex / Revenue
0.9%
6.6%
Cash ConversionOCF / Net Profit
2.00×
1.55×
TTM Free Cash FlowTrailing 4 quarters
$829.9M
$917.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HAS
HAS
STE
STE
Q4 25
$403.2M
$298.2M
Q3 25
$280.6M
$287.8M
Q2 25
$71.3M
$420.0M
Q1 25
$138.1M
$260.8M
Q4 24
$259.8M
$332.8M
Q3 24
$222.5M
$250.7M
Q2 24
$187.3M
$303.7M
Q1 24
$177.8M
$254.8M
Free Cash Flow
HAS
HAS
STE
STE
Q4 25
$389.5M
$199.5M
Q3 25
$260.9M
$201.3M
Q2 25
$55.2M
$326.4M
Q1 25
$124.3M
$189.9M
Q4 24
$200.8M
$243.6M
Q3 24
$174.0M
$148.8M
Q2 24
$135.4M
$195.7M
Q1 24
$132.0M
$163.3M
FCF Margin
HAS
HAS
STE
STE
Q4 25
26.9%
13.3%
Q3 25
18.8%
13.8%
Q2 25
5.6%
23.5%
Q1 25
14.0%
12.8%
Q4 24
18.2%
17.8%
Q3 24
13.6%
11.2%
Q2 24
13.6%
15.3%
Q1 24
17.4%
14.6%
Capex Intensity
HAS
HAS
STE
STE
Q4 25
0.9%
6.6%
Q3 25
1.4%
5.9%
Q2 25
1.6%
6.7%
Q1 25
1.6%
4.8%
Q4 24
5.4%
6.5%
Q3 24
3.8%
7.7%
Q2 24
5.2%
8.4%
Q1 24
6.0%
8.2%
Cash Conversion
HAS
HAS
STE
STE
Q4 25
2.00×
1.55×
Q3 25
1.20×
1.50×
Q2 25
2.37×
Q1 25
1.40×
1.79×
Q4 24
1.92×
Q3 24
1.00×
1.67×
Q2 24
1.35×
2.09×
Q1 24
3.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HAS
HAS

Grow Brands$1.1B75%
Optimize Brands$188.7M13%
Digital And Licensing Gaming$135.7M9%
Class Of Principal Product Family Brands$13.1M1%
Filmand TV$2.4M0%

STE
STE

Servicerevenues$404.7M27%
Consumablerevenues$387.1M26%
Applied Sterilization Technologies$286.6M19%
Capitalequipmentrevenues$272.1M18%
Life Science$145.8M10%

Related Comparisons